Klotho, a new marker for osteoporosis and muscle strength in β-thalassemia major

Blood Cells, Molecules, and Diseases

Volumn 55, Issue 4, 2015, Pages 396-401

  Baldan, Alessandro ^a,c   Giusti, Andrea ^b   Bosi, Cristina ^a   Malaventura, Cristina ^a   Musso, Marco ^b   Forni, Gian Luca ^b   Volpato, Stefano ^a   Zuliani, Giovanni ^a   Borgna Pignatti, Caterina ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Fragility fractures; Hand grip strength; Klotho; Osteoporosis; Thalassemia major

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CREATININE; FERRITIN; KLOTHO PROTEIN; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D; BETA GLUCURONIDASE; BIOLOGICAL MARKER;

ADULT; ARTICLE; BETA THALASSEMIA; BONE DENSITY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYNAMOMETER; ELISA KIT; ELISA READER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; GRIP STRENGTH; HAND GRIP; HIP; HUMAN; KLOTHO PROTEIN BLOOD LEVEL; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; SARCOPENIA; THALASSEMIA MAJOR; X RAY BONE DENSITOMETER; BLOOD; BONE; CASE CONTROL STUDY; COMPLICATION; HAND STRENGTH; METABOLISM; MIDDLE AGED; OSTEOPOROTIC FRACTURES; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; BETA-THALASSEMIA; BIOMARKERS; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; GLUCURONIDASE; HAND STRENGTH; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES;

EID: 84943534454     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2015.08.004     Document Type: Article

References (34)

1. Borgna-Pignatti C., Gamberini M.R. Complications of thalassemia major and their treatment. Expert. Rev. Hematol. 2011, 4:353-366. 10.1586/ehm.11.29.
2. Borgna-Pignatti C., Rugolotto S., De Stefano P., Zhao H., Cappellini M.D., Del Vecchio G.C., et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004, 89:1187-1193.
3. Costin G., Kogut M.D., Hyman C.B., Ortega J.A. Endocrine abnormalities in thalassemia major. Am. J. Dis. Child. 1979, 133:497-502.
4. Borgna-Pignatti C., De Stefano P., Zonta L., Vullo C., De Sanctis V., Melevendi C., et al. Growth and sexual maturation in thalassemia major. J. Pediatr. 1985, 106:150-155.
5. Vogiatzi M.G., Macklin E.A., Trachtenberg F.L., Fung E.B., Cheung A.M., Vichinsky E., et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in north America. Br. J. Haematol. 2009, 146:546-556. 10.1111/j.1365-2141.2009.07793.x.
6. Origa R., Fiumana E., Gamberini M.R., Armari S., Mottes M., Sangalli A., et al. Osteoporosis in beta-thalassemia: clinical and genetic aspects. Ann. N. Y. Acad. Sci. 2005, 1054:451-456. 10.1196/annals.1345.051.
7. Jensen C.E., Tuck S.M., Agnew J.E., Koneru S., Morris R.W., Yardumian A., et al. High incidence of osteoporosis in thalassaemia major. J. Pediatr. Endocrinol. Metab. 1998, 11(Suppl. 3):975-977.
8. Jackson R.D., LaCroix A.Z., Gass M., Wallace R.B., Robbins J., Lewis C.E., et al. Calcium plus vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 2006, 354:669-683. 10.1056/NEJMoa055218.
9. Giusti A. Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials. J. Bone Miner. Metab. 2014, 32:606-615. 10.1007/s00774-014-0584-8.
10. Shiraki-Iida T., Aizawa H., Matsumura Y., Sekine S., Iida A., Anazawa H., et al. Structure of the mouse Klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett. 1998, 424:6-10.
11. Kuro-o M. Klotho. Pflugers Arch. 2010, 459:333-343. 10.1007/s00424-009-0722-7.
12. Quarles L. Endocrine functions of bone in mineral metabolism regulation. J. Clin. Invest. 2008, 118:23-27. 10.1172/JCI36479.3820.
13. Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 2004, 19:429-435. 10.1359/JBMR.0301264.
14. Imura A., Iwano A., Tohyama O., Tsuji Y., Nozaki K., Hashimoto N., et al. Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 2004, 565:143-147. 10.1016/j.febslet.2004.03.090.
15. Imura A., Tsuji Y., Murata M., Maeda R., Kubota K., Iwano A., et al. Alpha-Klotho as a regulator of calcium homeostasis. Science 2007, 316:1615-1618. 10.1126/science.1135901.
16. Alexander R.T., Woudenberg-Vrenken T.E., Buurman J., Dijkman H., van der Eerden B.C.J., van Leeuwen J.P.T.M., et al. Klotho prevents renal calcium loss. J. Am. Soc. Nephrol. 2009, 20:2371-2379. 10.1681/ASN.2008121273.
17. Nijenhuis T., Hoenderop J.G.J., Bindels R.J.M. TRPV5 and TRPV6 in Ca(2+) (re)absorption: regulating Ca(2+) entry at the gate. Pflugers Arch. 2005, 451:181-192. 10.1007/s00424-005-1430-6.
18. Lu P., Boros S., Chang Q., Bindels R.J., Hoenderop J.G. The beta-glucuronidase Klotho exclusively activates the epithelial Ca2+ channels TRPV5 and TRPV6. Nephrol. Dial. Transplant. 2008, 23:3397-3402. 10.1093/ndt/gfn291.
19. Tsuruoka S., Nishiki K., Ioka T., Ando H., Saito Y., Kurabayashi M., et al. Defect in parathyroid-hormone-induced luminal calcium absorption in connecting tubules of Klotho mice. Nephrol. Dial. Transplant. 2006, 21:2762-2767. 10.1093/ndt/gfl335.
20. Semba R.D., Cappola A.R., Sun K., Bandinelli S., Dalal M., Crasto C., et al. Relationship of low plasma Klotho with poor grip strength in older community-dwelling adults: the InCHIANTI study. Eur. J. Appl. Physiol. 2012, 112:1215-1220. 10.1007/s00421-011-2072-3.
21. Semba R.D., Cappola A.R., Sun K., Bandinelli S., Dalal M., Crasto C., et al. Plasma Klotho and cardiovascular disease in adults. J. Am. Geriatr. Soc. 2011, 59:1596-1601. 10.1111/j.1532-5415.2011.03558.x.
22. Semba R.D., Cappola A.R., Sun K., Bandinelli S., Dalal M., Crasto C., et al. Plasma klotho and mortality risk in older community-dwelling adults. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66:794-800. 10.1093/gerona/glr058.
23. Cohen D.D., Gómez-Arbeláez D., Camacho P.A., Pinzon S., Hormiga C., Trejos-Suarez J., et al. Low muscle strength is associated with metabolic risk factors in Colombian children: the ACFIES study. PLoS ONE 2014, 9. 10.1371/journal.pone.0093150.
24. Binkley N., Krueger D., Buehring B. What's in a name revisited: should osteoporosis and sarcopenia be considered components of "dysmobility syndrome?". Osteoporos. Int. 2013, 24:2955-2959. 10.1007/s00198-013-2427-1.
25. Wong P., Fuller P.J., Gillespie M.T., Kartsogiannis V., Milat F., Bowden D.K., et al. The effect of gonadal status on body composition and bone mineral density in transfusion-dependent thalassemia. Osteoporos. Int. 2014, 25:597-604. 10.1007/s00198-013-2454-y.
26. Mougeolle A., Poussard S., Decossas M., Lamaze C., Lambert O., Dargelos E. Oxidative stress induces caveolin 1 degradation and impairs caveolae functions in skeletal muscle cells. PLoS ONE 2015, 10. 10.1371/journal.pone.0122654.
27. Schutte J.E., Longhurst J.C., Gaffney F.A., Bastian B.C., Blomqvist C.G. Total plasma creatinine: an accurate measure of total striated muscle mass. J. Appl. Physiol. 1981, 51:762-766.
28. Glass D.J. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr. Top. Microbiol. Immunol. 2010, 346:267-278. 10.1007/82_2010_78.
29. Miyazaki M., Esser K.A. Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals. J. Appl. Physiol. 2009, 106:1367-1373. 10.1152/japplphysiol.91355.2008.
30. Kamei Y., Miura S., Suzuki M., Kai Y., Mizukami J., Taniguchi T., et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 2004, 279:41114-41123. 10.1074/jbc.M400674200.
31. Yamamoto M., Clark J., Pastror J., Gurnami P., Nandi A., Kuro-o M. Regulation of oxidative stress by the anti-aging hormone klotho. J. Biol. Chem. 2008, 280:38029-38034.
32. Saito Y., Yamagishi T., Nakamura T., Ohyama Y., Aizawa H., Suga T., et al. Klotho protein protects against endothelial dysfunction. Biochem. Biophys. Res. Commun. 1998, 248:324-329.
33. Saito Y., Nakamura T., Ohyama Y., Suzuki T., Iida A., Shikari-Iida T., et al. In vivo Klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem. Biophys. Res. Commun. 2000, 276:767-772. 10.1006/bbrc.2000.3470.
34. Chen C.-D., Tung T.Y., Liang J., Zeldich E., Tucker Zhou T.B., Turk B.E., et al. Identification of cleavage sites leading to the shed form of the anti-aging protein Klotho. Biochemistry 2014, 53:5579-5587. 10.1021/bi500409n.